RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury

Thrombosis and Haemostasis

Volumn 112, Issue 6, 2014, Pages 1110-1119

  Cabrera Fuentes, Hector A ^a,b   Ruiz Meana, Marisol ^c   Simsekyilmaz, Sakine ^d   Kostin, Sawa ^e   Inserte, Javier ^c   Saffarzadeh, Mona ^a   Galuska, Sebastian P ^a   Vijayan, Vijith ^a   Barba, Ignasi ^c   Barreto, Guillermo ^e   Fischer, Silvia ^a   Lochnit, Günter ^a   Ilinskaya, Olga N ^b   Baumgart Vogt, Eveline ^a   Böning, Andreas ^a   Lecour, Sandrine ^f   Hausenloy, Derek J ^g   Liehn, Elisa A ^d   Garcia Dorado, David ^c   Schlüter, Klaus Dieter ^a   Preissner, Klaus T ^a,b   more..

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiology; Cytokines; Inflammatory mediators; Ischaemic heart disease

Indexed keywords

8 (4 SULFOPHENYL) THEOPHYLLINE; ALPHA SMOOTH MUSCLE ACTIN; ANTIOXIDANT ENZYME; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD31 ANTIGEN; COLONY STIMULATING FACTOR 1 RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR; COPPER ZINC SUPEROXIDE DISMUTASE; CREATINE PHOSPHATE; ENZYME; EXTRACELLULAR RNA; EXTRACELLULAR SUPEROXIDE DISMUTASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LEUKOCYTE ELASTASE; MANGANESE SUPEROXIDE DISMUTASE; MAST CELL PROTEASE 6; OXYGEN RADICAL; PANCREATIC RIBONUCLEASE; PEROXIREDOXIN 3; REACTIVE OXYGEN METABOLITE; RIBONUCLEASE INHIBITOR; RNA; RNA 18S; RNA 28S; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE PROTEINASE; SUPEROXIDE DISMUTASE; TRYPTASE; TRYPTASE BETA 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIOXIDANT; RIBONUCLEASE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HYPOXIA; ISOLATED HEART; MEMBRANE MICROPARTICLE; MOUSE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; RNA DEGRADATION; RNA ISOLATION; ANIMAL; AUTOCRINE EFFECT; CELL HYPOXIA; CELL PROTECTION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEART MITOCHONDRION; HEART MUSCLE; IMMUNOLOGY; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; SIGNAL TRANSDUCTION; TIME;

ANIMALS; ANTIOXIDANTS; AUTOCRINE COMMUNICATION; CELL HYPOXIA; CYTOPROTECTION; DISEASE MODELS, ANIMAL; MICE; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; REACTIVE OXYGEN SPECIES; RIBONUCLEASES; RNA; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84914140035     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-08-0703     Document Type: Article

References (49)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121–1135.
2. Hausenloy DJ, Yellon DM. Myocardial ischaemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 2013; 123: 92–100.
3. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998; 38: 291–300.
4. Ruiz-Meana M, Abellan A, Miro-Casas E, et al. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes. Basic Res Cardiol 2007; 102: 542–552.
5. Di Lisa F, Carpi A, Giorgio V, et al. The mitochondrial permeability transition pore and cyclophilin D in cardioprotection. Biochim Biophys Acta 2011; 1813: 1316–1322.
6. Di Lisa F, Kaludercic N, Carpi A, et al. Mitochondria and vascular pathology. Pharmacol Rep 2009; 61: 123–130.
7. Abdallah Y, Wolf C, Meuter K, et al. Preconditioning with diazoxide prevents reoxygenation-induced rigor-type hypercontracture. J Mol Cell Cardiol 2010; 48: 270–276.
8. Ladilov Y, Efe O, Schafer C, et al. Reoxygenation-induced rigor-type contracture. J Mol Cell Cardiol 2003; 35: 1481–1490.
9. Garcia-Dorado D, Ruiz-Meana M, Inserte J, et al. Calcium-mediated cell death during myocardial reperfusion. Cardiovasc Res 2012; 94: 168–180.
10. Zhao Q, Shao L, Hu X, et al. Lipoxin a4 preconditioning and postconditioning protect myocardial ischaemia/reperfusion injury in rats. Mediators Inflam 2013; 2013: 231351.
11. Schafer C, Ladilov Y, Inserte J, et al. Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res 2001; 51: 241–250.
12. Ruiz-Meana M, Garcia-Dorado D, Julia M, et al. Protective effect of HOE642, a selective blocker of Na+-H+ exchange, against the development of rigor contracture in rat ventricular myocytes. Exp Physiol 2000; 85: 17–25.
13. Agullo L, Garcia-Dorado D, Escalona N, et al. Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes. Cardiovasc Res 2005; 68: 65–74.
14. Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007; 370: 575–579.
15. Thielmann M, Kottenberg E, Kleinbongard P, et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 2013; 382: 597–604.
16. Botker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010; 375: 727–734.
17. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013; 381: 166–175.
18. Ovize M, Thibault H, Przyklenk K. Myocardial conditioning: opportunities for clinical translation. Circ Res 2013; 113: 439–450.
19. Santos ES, Baltar VT, Pereira MP, et al. Comparison between cardiac troponin I and CK-MB mass in acute coronary syndrome without st elevation. Arqu Bras Cardiol 2011; 96: 179–187.
20. McErlean ES, Deluca SA, van Lente F, et al. Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. Am J Cardiol 2000; 85: 421–426.
21. Kannemeier C, Shibamiya A, Nakazawa F, et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci USA 2007; 104: 6388–6393.
22. Deindl E, Fischer S, Preissner KT. New directions in inflammation and immunity: the multi-functional role of the extracellular RNA/RNase system. Indian J Biochem Biophys 2009; 46: 461–466.
23. Fischer S, Gerriets T, Wessels C, et al. Extracellular RNA mediates endothelialcell permeability via vascular endothelial growth factor. Blood 2007; 110: 2457–2465.
24. Fischer S, Grantzow T, Pagel JI, et al. Extracellular RNA promotes leukocyte recruitment in the vascular system by mobilising proinflammatory cytokines. Thromb Haemost 2012; 108: 730–741.
25. Cerri C, Chimenti D, Conti I, et al. Monocyte/macrophage-derived microparticles up-regulate inflammatory mediator synthesis by human airway epithelial cells. J Immunol 2006; 177: 1975–1980.
26. Liehn EA, Piccinini AM, Koenen RR, et al. A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischaemia/reperfusion injury in mice. J Am Coll Cardiol 2010; 56: 1847–1857.
27. Grohe C, van Eickels M, Wenzel S, et al. Sex-specific differences in ventricular expression and function of parathyroid hormone-related peptide. Cardiovasc Res 2004; 61: 307–316.
28. Cabrera-Fuentes HA, Aslam M, Saffarzadeh M, et al. Internalisation of Bacillus intermedius ribonuclease (BINASE) induces human alveolar adenocarcinoma cell death. Toxicon 2013; 69: 219–226.
29. Inserte J, Barba I, Hernando V, et al. Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium. Cardiovasc Res 2009; 81: 116–122.
30. Abassi ZA, Barac YD, Kostin S, et al. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure. Circ Heart Fail 2011; 4: 463–473.
31. Rohman MS, Emoto N, Takeshima Y, et al. Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts. Biochem Biophys Res Commun 2003; 310: 228–235.
32. Simsekyilmaz S, Cabrera-Fuentes HA, Meiler S, et al. Role of extracellular RNA in atherosclerotic plaque formation in mice. Circulation 2014; 129: 598–606.
33. Acharya A, Baek ST, Huang G, et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012; 139: 2139–2149.
34. Vorderwinkler K P, Mair J, Puschendorf B, et al. Cardiac troponin I increases in parallel to cardiac troponin T, creatine kinase and lactate dehydrogenase in effluents from isolated perfused rat hearts after hypoxia-reoxygenation-induced myocardial injury. Clin Chim Acta 1996; 251: 113–117.
35. Fischer S, Cabrera-Fuentes HA, Noll T, et al. Impact of extracellular RNA on endothelial barrier function. Cell Tissue Res 2014; Epub ahead of print.
36. Fischer S, Gesierich S, Griemert B, et al. Extracellular RNA liberates tumor necrosis factor-alpha to promote tumor cell trafficking and progression. Cancer Res 2013; 73: 5080–5089.
37. Gilles S, Zahler S, Welsch U, et al. Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res 2003; 60: 608–616.
38. Carpi A, Menabo R, Kaludercic N, et al. The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischaemia/reperfusion injury. Biochim Biophys Acta 2009; 1787: 774–780.
39. Rodrigo R, Prieto JC, Castillo R. Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: molecular mechanisms and potential clinical applications. Clin Sci 2013; 124: 1–15.
40. Bai Y, Muqier, Murakami H, et al. Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels. Clin Exp Pharmacol Physiol 2011; 38: 658–665.
41. Bonner F, Borg N, Jacoby C, et al. Ecto-5’-nucleotidase on immune cells protects from adverse cardiac remodeling. Circ Res 2013; 113: 301–312.
42. Fischer S, Nishio M, Peters SC, et al. Signaling mechanism of extracellular RNA in endothelial cells. FASEB J 2009; 23: 2100–2109.
43. Fischer S, Preissner KT. Extracellular nucleic acids as novel alarm signals in the vascular system. Mediators of defence and disease. Hamostaseologie 2013; 33: 37–42.
44. Antoniak S, Boltzen U, Eisenreich A, et al. Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. J Thromb Haemost 2009; 7: 871–878.
45. Gedik N, Heusch G, Skyschally A. Infarct size reduction by cyclosporine A at reperfusion involves inhibition of the mitochondrial permeability transition pore but does not improve mitochondrial respiration. Arch Med Sci 2013; 9: 968–975.
46. Kleinbongard P, Heusch G, Schulz R. TNFalpha in atherosclerosis, myocardial ischaemia/reperfusion and heart failure. Pharmacol Therap 2010; 127: 295–314.
47. Skyschally A, Gres P, Hoffmann S, et al. Bidirectional role of tumor necrosis factor-alpha in coronary microembolisation: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 2007; 100: 140–146.
48. Kleinbongard P, Schulz R, Heusch G. TNFalpha in myocardial ischaemia/reperfusion, remodeling and heart failure. Heart Fail Rev 2011; 16: 49–69.
49. Lecour S, Suleman N, Deuchar GA, et al. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 2005; 112: 3911–3918.